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Arginase, which exists as the isoforms arginase I and II, catalyzes
the hydrolysis of arginine to ornithine and urea. Ornithine is the
principal precursor for production of polyamines, which are re-
quired for cell proliferation. Rat aortic smooth muscle cells
(RASMC) contain constitutive arginase I, and arginase inhibitors
cause inhibition of cell proliferation. The objective of this study
was to determine whether the elevated expression of arginase I in
RASMC causes increased cell proliferation. RASMC were stably
transfected with either rat arginase I cDNA or a b-galactosidase
control expression plasmid. Western blots and arginase enzymatic
assays revealed high-level expression of cytosolic arginase I in
arginase I-transfected RASMC. Moreover, this observation was
associated with the increased production of urea and polyamines
and higher rates of RASMC proliferation. The two selective inhib-
itors of arginase, NG-hydroxy-L-arginine and S-(2-boronoethyl)-L-
cysteine, inhibited arginase and decreased the production of urea
and polyamines in arginase I-transfected RASMC, all of which were
associated with the inhibition of cell proliferation. This study
demonstrates that elevated arginase I expression increases RASMC
proliferation by mechanisms involving increased production of
polyamines. These observations suggest that arginase I plays a
potentially important role in controlling RASMC proliferation.
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A therosclerosis is the underlying cause of coronary arterydisease, which, in turn, is the most common cause of
morbidity and untimely death in Western countries. An acute
attack is typically precipitated by thrombosis occurring at the site
of atherosclerotic plaque disruption. Atherosclerotic plaques
consist of a fibrous cap overlaying a lipid-rich cone. Many cell
types are involved in their formation, including platelets, endo-
thelial cells, smooth muscle cells (SMC), macrophages, and
leukocytes (1). A key event in the pathogenesis of the disease is
the migration and proliferation of SMC from the medial layer to
the intimal layer in arteries. Excessive intimal thickening con-
tributes to failures in vascular graft and angioplasty procedures
by causing luminal restenosis as a result of excessive SMC
growth. The precise mechanisms that control arterial SMC
proliferation have not been resolved. In an attempt to better
understand such mechanisms, we have found that rat aortic SMC
(RASMC) contain constitutive as well as IL-4- and IL-13-
inducible arginase I, and that both IL-4 and IL-13 stimulate
RASMC proliferation (2). Therefore, there seems to be a close
association between arginase activity and SMC proliferation.
Arginase (EC 3.5.3.1), which exists as two distinct isoforms
(arginase I and arginase II), catalyzes the conversion of arginine
to ornithine plus urea, and ornithine decarboxylase (ODC)
catalyzes the subsequent conversion of ornithine to putrescine
(3). Putrescine and decarboxylated S-adenosylmethionine serve
as substrates for the subsequent synthesis of spermidine, which
is a precursor of spermine. Polyamines (putrescine, spermidine,
and spermine) are required components for the progression of
the cell cycle and, as such, play an important role in cell
proliferation (4, 5). We hypothesized that at least one of the
mechanisms by which IL-4 and IL-13 stimulate RASMC prolif-
eration is by up-regulation of arginase I, which subsequently
makes more ornithine available for polyamine synthesis (2). Our
objective in the present study was to test this hypothesis by
determining whether elevated arginase I expression in RASMC
stimulates cell proliferation, and whether this effect is mediated
by mechanisms involving increased polyamine production. The
present study uses gene transfection specifically to manipulate
the expression of arginase I to study its impact on cell prolifer-
ation in RASMC.
Materials and Methods
Chemicals and Solutions. Cell-culture medium, supplements, and
reagents for urea determination, arginase assay, and protein
determination were described (6). NG-hydroxy-L-arginine
(NOHA) was obtained from Cayman Chemicals (Ann Arbor,
MI). S-nitroso-N-acetylpenicillamine (SNAP) was synthesized
as described (7). S-(2-boronoethyl)-L-cysteine (BEC) was a
generous gift from D. W. Christianson (Univ. of Pennsylvania,
Philadelphia).
Vector Construction and Transfection of RASMC. pEF1-rARGI, a
mammalian expression plasmid for rat arginase I, was con-
structed by inserting the EcoRI–BsaAI 1194-bp coding region
fragment of pARGr-2 (8) into the EcoRIyPmeI sites of the
plasmid pEF1yMyc-His C. No additional epitope sequences
were fused to the arginase I coding sequence in this construct.
For control transfection, the b-galactosidase expression plasmid
(pEF1yMyc-HisylacZ) alone, which contains the Escherichia
coli lacZ gene under control of the human elongation factor
(EF)-1a promoter (Invitrogen), was used to represent the ex-
pression of an unrelated exogenous protein. RASMC were
transfected with pEF1yrARGI or pEF1yMyc-HisylacZ by us-
ing Lipofectamine (Life Technologies, Rockville, MD) accord-
ing to the manufacturer’s instructions. Stably transfected cells
were selected with the antibiotic G418 (500 mgyml) in complete
DMEM. Cells were maintained at 37°C in complete DMEM
containing 10% (volyvol) FBS and 500 mgyml G418. After ’3
weeks, G418-resistant clones were isolated and analyzed indi-
vidually for expression of arginase I. The individual clones were
grown in DMEM containing 10% (volyvol) FBS and 250 mgyml
G418. The G418 was omitted from the cell-culture medium
beginning 2 days before initiating any experiments. Stably trans-
fected RASMC were examined for expression of arginase I by
Western blot analysis as described (2).
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Cell Culture of RASMC and Measurement of Cell Proliferation.
RASMC was a generous gift from S. Gross (Cornell Medical
College, New York). Cells were plated, grown, subcultured, and
cultured as described (2). In determining the rates of DNA
synthesis, a modification of the [methyl-3H]thymidine incorpo-
ration procedure described (9) was used, and cell proliferation
data are expressed as a percent of control (9, 10).
Arginase Assay. Arginase activity was determined by methods that
we have described (6). Briefly, RASMC (5 3 106 cells per
sample) were washed twice with ice-cold PBS, harvested, pel-
leted by centrifugation, and then lysed. Supernatant fractions
were assayed for arginase activity under optimal conditions of
pH (9.6) and L-arginine concentration (20 mM) by monitoring
the conversion of L-[guanido-14C]arginine to [14C]urea during a
10-min incubation.
Determination of Urea Concentrations in Cell-Culture Media.
RASMC were analyzed for urea production by determination of
urea released into the cell-culture medium. Cell-culture media
were collected and analyzed spectrophotometrically for urea
exactly as described (6).
Determination of Polyamine Concentrations in Cells. The concentra-
tions of putrescine, spermidine, and spermine in RASMC were
determined by a sensitive HPLC procedure (11). Brief ly,
RASMC were plated at a density of 106 cells per 100-mm dish
and grown to 80% confluence before the start of experiments.
Transfected cells (6 3 106 cells) were rinsed with PBS and then
incubated at 37°C for 24 hr in complete DMEM containing 0.5%
FBS and 0.4 mM L-arginine. After 24 hr, the cells were rapidly
washed twice with ice-cold PBS and then lysed in 0.5 ml of 1.5
M HClO4, and the solution was neutralized by the addition of
0.25 ml of 2 M K2CO3. The neutralized extracts were used for the
determination of polyamines.
Statistical Analyses. Where indicated, data were analyzed statis-
tically by using the Bonferroni t test for unpaired values. Values
of P , 0.05 were taken to indicate statistical significance.
Results
Elevated Expression of Arginase I in RASMC. RASMC were stably
transfected to express either rat arginase I or bacterial b-galac-
tosidase (LacZ), the latter representing the control for expres-
sion of an unrelated cytosolic protein. Western blots demon-
strated that RASMC transfected with rat arginase I cDNA
expressed high levels of arginase I protein (Fig. 1). Control
RASMC contained a much smaller quantity of arginase I present
constitutively, which was not altered quantitatively by cell trans-
fection with LacZ. Increased catalytic activity of arginase I in
arginase I-transfected RASMC was confirmed by analysis of cell
extracts for arginase activity. The specific activity of arginase in
extracts of arginase I-transfected cells was 8- to 10-fold higher
than that in either control RASMC or LacZ-transfected cells
(Fig. 2). Consistent with the data on Western blot analysis and
arginase activity, the production of urea by arginase I-
transfected cells was 4-fold greater than that by control or
LacZ-transfected cells (Fig. 3).
Fig. 1. Arginase I expression in RASMC stably transfected with rat arginase
I cDNA. Control (CTL) represents untransfected RASMC; LacZ represents
RASMC transfected with a b-galactosidase expression plasmid; AI represents
RASMC transfected with a rat arginase I expression plasmid. Twenty micro-
grams of protein was loaded in each lane, and immunoreactive arginase I was
detected by Western blot analysis. RASMC (5 3 106 cells per dish) were
incubated at 37°C in cell-culture medium for 24 hr and then harvested,
washed, and lysed. Cell lysates were used for Western blot analysis. Data
illustrated are from a single experiment and are representative of a total of
five separate experiments.
Fig. 2. Arginase I activity in RASMC stably transfected with rat arginase I
cDNA. Control represents untransfected RASMC; LacZ represents RASMC
transfected with a b-galactosidase expression plasmid; AI represents RASMC
transfected with a rat arginase I expression plasmid. RASMC (5 3 106 cells per
dish) were incubated at 37°C in cell-culture medium for 24 hr and then
harvested, washed, and lysed; cell lysates were used for the determination of
arginase activity. Cell lysates were the same cell lysates used for Western blot
analysis (Fig. 1). Arginase activity was determined by monitoring the conver-
sion of L-[guanido-14C]arginine to [14C]urea. Data represent means 6 SE of
duplicate determinations from five separate experiments. *, P , 0.05, signif-
icantly different from Control.
Fig. 3. Urea production as a measure of arginase activity in RASMC stably
transfected with rat arginase I cDNA. LacZ represents RASMC transfected with
a b-galactosidase expression plasmid; AI represents RASMC transfected with a
rat arginase I expression plasmid. RASMC (5 3 106 cells per dish) were incu-
bated at 37°C in cell-culture medium for 24 hr and then harvested, washed,
and lysed; cell lysates were used for urea determinations. Data represent
means 6 SE of duplicate determinations from five separate experiments. *, P ,
0.05, significantly different from Control.
Wei et al. PNAS u July 31, 2001 u vol. 98 u no. 16 u 9261
M
ED
IC
A
L
SC
IE
N
CE
S
Influence of Elevated Arginase I Expression on Polyamine Production
and Proliferation in RASMC. Arginase I-transfected cells showed
significantly higher levels of polyamines than LacZ-transfected
cells (Fig. 4). Putrescine increased by 208%, spermidine in-
creased by 186%, and spermine increased by 202% compared
with LacZ-transfected cells. The concentration of putrescine in
cells is generally about one to two orders of magnitude lower
than that of either spermidine or spermine (5, 10, 11). The actual
values for putrescine concentrations ranged from 0.20 6 0.03 to
0.41 6 0.06 nmol per 6 3 106 cells for LacZ-transfected RASMC
and arginase I-transfected RASMC, respectively. The increase in
polyamine production correlated with the increase in cell pro-
liferation observed in arginase I-transfected RASMC (Fig. 5).
Arginase I-transfected RASMC showed over a 60% increase in
the rate of cell proliferation when compared with LacZ-
transfected RASMC as determined by thymidine incorporation
into DNA.
Influence of Arginase Inhibitors and NO on Polyamine Production and
Proliferation in Arginase I-Transfected RASMC. The data presented
above suggest that increased arginase I expression in RASMC
leads to the increased proliferation of RASMC, and that in-
creased growth may be attributed to increased polyamine pro-
duction. Accordingly, the argument follows that inhibitors of
arginase should cause both a decrease in polyamine production
as well as a decrease in cell proliferation. Reports from this
laboratory have indicated that arginase inhibitors and NO
interfere with the proliferation of tumor cells and vascular SMC
(9, 10). In contrast to the arginase inhibitors, NO interferes with
cell growth by inhibiting ODC which, in turn, should lead to
decreased polyamine production. In the present series of exper-
iments, two arginase inhibitors and NO were compared with
respect to their effects in arginase I-transfected RASMC. Fig. 6
illustrates that two arginase inhibitors, NOHA and BEC, and the
NO donor agent, SNAP, each inhibited the proliferation of
arginase I-transfected RASMC in a concentration-dependent
manner.
Each of the two arginase inhibitors, but not SNAP, caused
inhibition of arginase activity after incubation with arginase
I-transfected RASMC (Fig. 7). Consistent with these findings,
NOHA and BEC inhibited urea production by these cells (Fig.
8), whereas SNAP did not alter urea production (data not
shown). To be certain that neither the arginase inhibitors nor
SNAP was interfering with arginase I expression during cell
culture, Western blot analysis was performed, and the data (Fig.
9) indicate clearly that none of the test agents interfered with
arginase I expression in arginase I-transfected RASMC. The
Fig. 4. Polyamine production in RASMC stably transfected with rat arginase
I cDNA. LacZ (white bars) represents RASMC transfected with a b-galactosidase
expression plasmid; AI (black bars) represents RASMC transfected with a rat
arginase I expression plasmid. RASMC (6 3 106 cells per dish) were incubated
at 37°C for 24 hr in complete DMEM containing 0.4 mM L-arginine and 0.5%
FBS. Cells were then harvested, washed, and extracted as described in the text.
Data represent means 6 SE of duplicate determinations from three separate
experiments. *, P , 0.05, significantly different from corresponding LacZ
controls.
Fig. 5. Influence of increased arginase I expression on RASMC proliferation.
LacZ represents RASMC transfected with a b-galactosidase expression plasmid;
AI represents RASMC transfected with a rat arginase I expression plasmid. Cell
proliferation was assessed by thymidine incorporation into DNA during the
second day (24 hr) of a 2-day growth period as described in the text. Data were
calculated as dpm per 105 cells per well and expressed as a percent of LacZ
control (assigned 100%). Data represent means 6 SE of duplicate determina-
tions from four separate experiments. *, P , 0.05, significantly different from
LacZ control.
Fig. 6. Influence of arginase inhibitors and NO on the proliferation of
RASMC stably transfected with rat arginase I cDNA. RASMC were transfected
with a rat arginase I expression plasmid. Cell proliferation was assessed by
thymidine incorporation into DNA during the second day (24 hr) of a 2-day
growth period as described in the text. Test agents were added to the cells at
the time of thymidine addition. Data were calculated as dpm per 105 cells per
well and expressed as a percent of control (CTL; absence of added test agents;
assigned 100%). CTL, arginase I-transfected RASMC. Data represent means 6
SE of duplicate determinations from four separate experiments. *, P , 0.05,
significantly different from CTL.
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probable mechanism by which NOHA, BEC, and SNAP inter-
fere with proliferation of arginase I-transfected RASMC is
inhibition of polyamine production (Fig. 10). NOHA, BEC, and
SNAP, each at 100 mM, significantly inhibited the production of
putrescine, spermidine, and spermine. The percentage inhibition
of polyamine production ranged from 35% to 65%.
Discussion
There are two distinct isoforms of mammalian arginase (arginase
I and arginase II) that are encoded by different genes and differ
in molecular and immunological properties, tissue distribution,
subcellular location, and regulation of expression (12, 13).
Arginase I is highly expressed in the liver of higher animals to
detoxify ammonia. Arginase I is also expressed to a much lesser
extent in other cell types. Because extrahepatic tissues do not
possess a complete urea cycle, the physiological effects of
arginase I in those cells are unclear. The present study shows that
elevated expression of arginase I markedly increases cellular
DNA synthesis by RASMC, suggesting that arginase is important
not only in the urea cycle but also in biochemical pathways
essential to controlling cell proliferation. The importance of
arginase in cell growth is supported by the knowledge that
arginase is the principal enzyme that generates ornithine, the
substrate for ODC. In turn, ODC catalyzes the conversion of
ornithine to putrescine, a polyamine that serves as the precursor
for two additional polyamines, spermidine and spermine. These
polyamines are required for cell proliferation and seem to
function by binding to DNA and modulating DNA–protein
interactions (4, 5). The present findings that cellular polyamine
levels increase about 2-fold in arginase I-transfected RASMC
Fig. 7. Influence of arginase inhibitors and NO on arginase activity in RASMC
stably transfected with rat arginase I cDNA. RASMC were transfected with a rat
arginase I expression plasmid. RASMC (5 3 106 cells per dish) were incubated
in the absence or presence of test agents at 37°C in cell-culture medium for 24
hr and then harvested, washed, and lysed; cell lysates were used for determi-
nation of arginase activity. Arginase activity was determined by monitoring
the conversion of L-[guanido-14C]arginine to [14C]urea. Control (CTL), arginase
I-transfected RASMC. Data represent means 6 SE of duplicate determinations
from three separate experiments. *, P , 0.05, significantly different from CTL.
Fig. 8. Influence of arginase inhibitors on urea production in RASMC stably
transfected with rat arginase I cDNA. RASMC were transfected with a rat
arginase I expression plasmid. RASMC (5 3 106 cells per dish) were incubated
in the absence or presence of test agents at 37°C in cell-culture medium for 24
hr and then harvested, washed, and lysed; cell lysates were used for urea
determinations. Control (CTL), arginase I-transfected RASMC. Data represent
means 6 SE of duplicate determinations from three separate experiments. *,
P , 0.05, significantly different from CTL.
Fig. 9. Influence of arginase inhibitors and NO on arginase I expression in
RASMC stably transfected with rat arginase I cDNA. AI represents RASMC
transfected with a rat arginase I expression plasmid; LacZ represents RASMC
transfected with a b-galactosidase expression plasmid. Twenty micrograms of
protein was loaded in each lane, and immunoreactive arginase I was detected
by Western blot analysis. RASMC (5 3 106 cells per dish) were incubated at 37°C
in cell-culture medium for 24 hr in the absence or presence of 100 mM NOHA,
100 mM BEC, or 100 mM SNAP as indicated. Cells were then harvested, washed,
and lysed; cell lysates were used for Western blot analysis. Data illustrated are
from a single experiment and are representative of a total of four separate
experiments.
Fig. 10. Influence of arginase inhibitors and NO on polyamine production in
RASMC stably transfected with rat arginase I cDNA. RASMC (6 3 106 cells per
dish) were incubated at 37°C for 24 hr in complete DMEM containing 0.4 mM
L-arginine, 0.5% FBS, and test agents as indicated. Cells were then harvested,
washed, and extracted as described in the text. NOHA, BEC, and SNAP, each at
100 mM, significantly inhibited the production of putrescine (white bars),
spermidine (hatched bars), and spermine (black bars). Data represent means 6
SE of duplicate determinations from three separate experiments. *, P , 0.05,
significantly different from corresponding Control values.
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compared with LacZ-transfected cells support this view. These
results are consistent with the view that arginase I-transfected cells
produce more ornithine that is available for ODC, which subse-
quently produces more polyamines to support cell proliferation.
We have shown that NOHA, the major intermediate in the
NO synthase-catalyzed conversion of arginine to NO and cit-
rulline, is a potent inhibitor of both arginase and tumor-cell
proliferation (9). Arginase is a binuclear Mn21 metalloenzyme
with a high binding affinity for boronic acid-based arginine
analogs (14). BEC is one such analog and has been reported to
be more potent than NOHA as an arginase inhibitor (14). Both
NOHA and BEC are competitive inhibitors of arginase (15). In
the present study, we found that arginase catalytic activity and
urea production, but not arginase I protein expression, were
markedly inhibited by NOHA and BEC in arginase I-transfected
RASMC. These observations indicate that both arginase inhib-
itors permeate cells and decrease intracellular arginase activity.
Inhibition of arginase activity and urea production was associ-
ated with a concomitant inhibition of polyamine production and
cell proliferation in arginase I-transfected RASMC. These ob-
servations support the hypothesis that arginase activity is im-
portant in maintaining cell proliferation and that interference
with the production of ornithine can result in impaired poly-
amine production and decreased cell proliferation.
NO also inhibits cell proliferation, and the mechanism seems
to be cGMP-independent and attributed to the inhibition of
ODC (9, 10, 16). In this regard, the action of NO resembles the
action of the well known ODC inhibitor a-dif luoromethylorni-
thine, which has been shown to inhibit polyamine production in
and proliferation of RASMC (10). The mechanism of inhibition
of ODC by NO donor agents such as SNAP seems to be
S-nitrosation of the active site Cys-360 residue by transnitrosa-
tion, thereby inactivating the enzyme because the Cys-360
sulfhydryl is essential for the expression of ODC catalytic activity
(17, 18). The present data indicate that SNAP inhibits prolifer-
ation and polyamine production in arginase I-transfected
RASMC by mechanisms that do not involve the inhibition of
arginase activity. The mechanism by which SNAP interferes with
the proliferation of arginase I-transfected RASMC is likely to be
the same as that in control RASMC, namely, by inhibition of
ODC. The present study demonstrates that both arginase I and
ODC are important enzymes in controlling polyamine synthesis
and proliferation in RASMC. The findings that these two
sequential enzymes in the polyamine pathway are inhibited by
two products of NO synthase (NOHA and NO) argue for a
modulatory role for the arginine-NO pathway in vascular SMC
proliferation.
ODC often has been considered to be the first and rate-
limiting enzyme in polyamine synthesis from ornithine (19).
However, this view was expressed before the availability of
potent arginase inhibitors to test this hypothesis more vigorously.
The data provided in this study using RASMC show clearly that
overexpression with arginase I results in enhanced polyamine
production and increased rates of cell proliferation. Moreover,
two different arginase inhibitors cause reductions in polyamine
production as well as cell proliferation. We do find, however, that
the NO donor agent, SNAP, is more effective than NOHA or
BEC in slowing cell proliferation despite the fact that their
potencies as inhibitors of arginase or ODC are quite similar (9,
10, 14–16). Therefore, the ODC enzymatic reaction may be
somewhat slower and more rate-limiting than the arginase
reaction under certain conditions but, nevertheless, inhibition of
either reaction can lower polyamine production and decrease
cell proliferation.
Coronary artery disease and atherosclerosis in general are
considered to be chronic inflammatory processes characterized
by the invasion of vascular tissue by circulating blood cells such
as monocytes, which then proliferate and elaborate factors that
cause the underlying vascular SMC to proliferate, eventually
resulting in plaque formation, lumen occlusion, and plaque
rupture (20). Cytokines such as IL-4 and IL-13 produced in
humans by activated CD41 cells have been found to be the
predominant T cells in atherosclerotic lesions (21, 22). We have
demonstrated that both IL-4 and IL-13 can up-regulate arginase
I expression in RASMC and stimulate cell proliferation (2).
Based on these observations and those of the present study, we
forward the hypothesis that during atherogenesis, cytokines
produced by local cells may up-regulate arginase I expression in
SMC and thereby lead to increased rates of cell proliferation. In
conclusion, the present study suggests that arginase I acts as a
primary step in the pathway to polyamine formation and cell
proliferation. This knowledge may aid in the understanding of
the mechanisms that control vascular SMC proliferation under
both physiological and pathophysiological conditions such as
atherosclerosis, restenosis, and angiogenesis.
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